FDA Determines Regulatory Review Period for ZYKADIA Patent Extension

Summary

The US Food and Drug Administration (FDA) has officially confirmed the regulatory review period for ZYKADIA, a human drug product, in accordance with the law, following a submission to the US Patent and Trademark Office (USPTO).